The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. | Semantic Scholar Skip to search formSkip to main content> Semantic Scholar's Logo Search Sign InCreate Free Account You are currently offline. Some features of the site may not work correctly. DOI:10.1176/appi.ajp.2015.173501 Corpus ID: 5638601The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. @article{Reus2016TheAP, title={The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.}, author={V. Reus and L. Fochtmann and A. E. Eyler and D. Hilty and M. Horvitz-Lennon and M. Jibson and O. Lopez and J. Mahoney and Jagoda Pasic and Z. Tan and C. Wills and Richard S. Rhoads and J. Yager}, journal={The American journal of psychiatry}, year={2016}, volume={173 5}, pages={ 543-6 } } V. Reus, L. Fochtmann, +10 authors J. Yager Published 2016 Medicine The American journal of psychiatry anagement of behavioral disturbances Mand psychosis associated with dementia is a clinical and, in some cases, a medicolegal and ethical challenge for clinicians, caregivers, and health care settings. These medications are associated with multiple adverse outcomes, including serious adverse effects, such as increased risk for cerebrovascular events and mortality. At the same time, clinicians feel pressure from caregivers, acute inpatient staff, and long-term care settings to safely manage… Expand View on PubMed ajp.psychiatryonline.org Save to Library Create Alert Cite Launch Research Feed Share This Paper 130 CitationsHighly Influential Citations 10 Background Citations 33 Methods Citations 4 View All Figures, Tables, and Topics from this paper table A1 table A10 table A10 table A10 table A13 table A14 table A14 table A16 table A16 table A16 table A17 table A17 table A18 table A19 table A2 table A20 table A20 table A21 table A21 table A22 table A22 table A22 table A23 table A24 table A24 table A24 table A25 table A26 table A28 table A3 table A3 table A30 table A31 table A32 table A34 table A34 table A35 table A36 table A37 table A37 table A38 table A4 table A4 table A40 table A40 table A41 table A42 table A42 table A43 table A5 table A5 table A6 table A6 table A6 table A7 table A8 table A9 table A9 table B1 figure B1 figure B10 figure B11 figure B12 figure B13 figure B14 figure B15 figure B16 figure B17 figure B2 table B2 figure B20 figure B21 figure B22 figure B22 figure B22 figure B23 figure B3 table B3 figure B4 table B4 figure B5 figure B6 figure B7 figure B8 figure B9 View All 85 Figures & Tables Psychotic Disorders Antipsychotic Agents Achyrocline Independent Practice Associations Mental disorders Agitation Volition Paper Mentions Blog Post Risks of Antipsychotics for Treatment of Delirium May Outweigh Benefits, Review Finds Psych News Alert 6 September 2019 130 Citations Citation Type Citation Type All Types Cites Results Cites Methods Cites Background Has PDF Publication Type Author More Filters More Filters Filters Sort by Relevance Sort by Most Influenced Papers Sort by Citation Count Sort by Recency Antipsychotic Use in Dementia J. Kirkham, Chelsea Sherman, +4 authors D. Seitz Medicine Canadian journal of psychiatry. Revue canadienne de psychiatrie 2017 27 Save Alert Research Feed New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin F. Caraci, Mario Santagati, +4 authors F. Drago Medicine F1000Research 2020 3 PDF Save Alert Research Feed Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates M. Marcinkowska, Joanna Śniecikowska, N. Fajkis, P. Paśko, Weronika Franczyk, M. Kołaczkowski Medicine CNS Drugs 2020 3 Highly Influenced PDF View 1 excerpt, cites background Save Alert Research Feed Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA Stephanie V Phan, Sharmon P. Osae, J. Morgan, Mfon Inyang, S. Fagan Medicine Drugs in R&D 2019 9 Highly Influenced PDF View 4 excerpts, cites background and methods Save Alert Research Feed Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram N. Herrmann Psychology, Medicine Evidence-Based Mental Health 2016 1 View 1 excerpt, cites background Save Alert Research Feed Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia. W. Deardorff, G. Grossberg Medicine Handbook of clinical neurology 2019 10 Save Alert Research Feed Neuropsychiatric symptoms in dementia. R. Radue, Art Walaszek, S. Asthana Medicine Handbook of clinical neurology 2019 Save Alert Research Feed Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study. C. H. Smeets, S. Zuidema, +4 authors H. Luijendijk Medicine Journal of clinical epidemiology 2018 3 Save Alert Research Feed Cost-effectiveness of atypical antipsychotics for the treatment of dementia in Thailand Oranuch Thongchundee Medicine 2019 PDF Save Alert Research Feed Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer's disease: A naturalistic and multicenter study L. F. Oliveira, E. Camargos, M. G. Novaes Medicine Psychiatry Research 2021 Save Alert Research Feed ... 1 2 3 4 5 ... References SHOWING 1-10 OF 196 REFERENCES SORT BYRelevance Most Influenced Papers Recency Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel H. Kales, L. Gitlin, C. Lyketsos Medicine Journal of the American Geriatrics Society 2014 272 View 1 excerpt Save Alert Research Feed Don’t use antipsychotics routinely to treat agitation and aggression in people with dementia A. Corbett, A. Burns, C. Ballard Medicine BMJ : British Medical Journal 2014 62 PDF View 1 excerpt, references background Save Alert Research Feed Assessment and management of behavioral and psychological symptoms of dementia H. Kales, L. Gitlin, C. Lyketsos Medicine BMJ : British Medical Journal 2015 453 PDF Save Alert Research Feed Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. T. Declercq, M. Petrovic, +4 authors T. Christiaens Medicine The Cochrane database of systematic reviews 2013 176 PDF Save Alert Research Feed Antipsychotic Drug Use and Mortality in Older Adults with Dementia S. Gill, S. Bronskill, +9 authors P. Rochon Medicine Annals of Internal Medicine 2007 522 PDF Save Alert Research Feed Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment S. Finkel, J. Costa E. Silva, G. Cohen, S. Miller, N. Sartorius Medicine, Psychology International psychogeriatrics 1996 223 View 1 excerpt, references background Save Alert Research Feed The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. O. Lopez, J. Becker, +9 authors W. Klunk Medicine The American journal of psychiatry 2013 89 Save Alert Research Feed Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. D. Maust, H. Kim, +4 authors H. Kales Medicine JAMA psychiatry 2015 318 PDF View 1 excerpt, references background Save Alert Research Feed Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events R. Moretti, P. Torre, R. M. Antonello, T. Cattaruzza, G. Cazzato Medicine Journal of Neurology 2005 30 Save Alert Research Feed Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. V. Gardette, M. Lapeyre-Mestre, +4 authors S. Andrieu Medicine Current Alzheimer research 2012 31 Save Alert Research Feed ... 1 2 3 4 5 ... Related Papers Abstract Figures, Tables, and Topics Paper Mentions 130 Citations 196 References Related Papers Stay Connected With Semantic Scholar Sign Up About Semantic Scholar Semantic Scholar is a free, AI-powered research tool for scientific literature, based at the Allen Institute for AI. Learn More → Resources DatasetsSupp.aiAPIOpen Corpus Organization About UsResearchPublishing PartnersData Partners   FAQContact Proudly built by AI2 with the help of our Collaborators Blog posts, news articles and tweet counts and IDs sourced by Altmetric.com Terms of Service•Privacy Policy The Allen Institute for AI By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License ACCEPT & CONTINUE